{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:13:22Z","timestamp":1770009202000,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.eprac.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T18:15:17Z","timestamp":1626718517000},"page":"1199-1204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-888X","authenticated-orcid":false,"given":"Davut","family":"Sakiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Erkam","family":"Sencar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Calapkulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilknur","family":"Ozturk Unsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir","family":"Ucan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eprac.2021.07.011_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.eprac.2021.07.011_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/ASO.2004.03.066","article-title":"Thyroid cancer: is the incidence still increasing?","volume":"11","author":"Hodgson","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"9356","key":"10.1016\/j.eprac.2021.07.011_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.011_bib4","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"10.1016\/j.eprac.2021.07.011_bib5","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1001\/jama.2019.18528","article-title":"Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016","volume":"322","author":"Powers","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"4-5","key":"10.1016\/j.eprac.2021.07.011_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib9","doi-asserted-by":"crossref","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","article-title":"Hashimotos\u2019 thyroiditis: epidemiology, pathogenesis, clinic and therapy","volume":"33","author":"Ragusa","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000486367","article-title":"Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer","volume":"7","author":"Babli","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.011_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/1471-2407-12-610","article-title":"The clinical features of papillary thyroid cancer in Hashimoto\u2019s thyroiditis patients from an area with a high prevalence of Hashimoto\u2019s disease","volume":"12","author":"Zhang","year":"2012","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.eprac.2021.07.011_bib12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4158\/E151078.OR","article-title":"Lymphocytic thyroiditis is associated with increased number of benign cervical nodes and fewer central neck compartment metastatic lymph nodes in patients with differentiated thyroid cancer","volume":"22","author":"Donangelo","year":"2016","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.surg.2013.07.021","article-title":"The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma","volume":"154","author":"Jara","year":"2013","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.011_bib14","first-page":"1","article-title":"The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer?","volume":"33","author":"Del Rio","year":"2008","journal-title":"Minerva Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.011_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s002680020165","article-title":"Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited","volume":"25","author":"Kebebew","year":"2001","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib16","first-page":"596","article-title":"Interleukin-1 inhibits human thyroid carcinoma cell growth","volume":"75","author":"Kimura","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2021.07.011_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0046-8177(96)90346-9","article-title":"Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma","volume":"27","author":"Lucas","year":"1996","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.011_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.1998.8.197","article-title":"Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma","volume":"8","author":"Kashima","year":"1998","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib19","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1210\/jc.2013-1309","article-title":"Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis","volume":"98","author":"Dvorkin","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.011_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2021.07.011_bib21","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","article-title":"Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland","volume":"70","author":"Dailey","year":"1955","journal-title":"AMA Arch Surg"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12022-020-09653-y","article-title":"The association of histologically proven chronic lymphocytic thyroiditis with clinicopathological features, lymph node metastasis, and recurrence rates of differentiated thyroid cancer","volume":"32","author":"Aydo\u011fan","year":"2021","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib24","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1007\/s13277-015-4534-4","article-title":"The impact of coexistent Hashimoto\u2019s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma","volume":"37","author":"Qu","year":"2016","journal-title":"Tumour Biol"},{"issue":"4","key":"10.1016\/j.eprac.2021.07.011_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3803\/EnM.2018.33.4.473","article-title":"Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies","volume":"33","author":"Moon","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.011_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.13335","article-title":"Crucial parameters in thyroid carcinoma reporting\u2014challenges, controversies and clinical implications","volume":"72","author":"Xu","year":"2018","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.eprac.2021.07.011_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1530\/ERC-16-0123","article-title":"Lymphovascular invasion is associated with survival for papillary thyroid cancer","volume":"23","author":"Pontius","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.011_bib28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41598-020-58425-5","article-title":"Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion","volume":"10","author":"Rowe","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.011_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0903","article-title":"The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis","volume":"168","author":"Lee","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.011_bib30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00268-019-05337-9","article-title":"The association between chronic lymphocytic thyroiditis and the progress of papillary thyroid cancer","volume":"44","author":"Lee","year":"2020","journal-title":"World J Surg"},{"issue":"10","key":"10.1016\/j.eprac.2021.07.011_bib31","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1089\/thy.2015.0104","article-title":"Survival from differentiated thyroid cancer: what has age got to do with it?","volume":"25","author":"Ganly","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4158\/EP13029.OR","article-title":"Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer?","volume":"19","author":"Bischoff","year":"2013","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.eprac.2021.07.011_bib33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-0043-117892","article-title":"Hashimoto\u2019s thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults","volume":"49","author":"Liu","year":"2017","journal-title":"Horm Metab Res"},{"issue":"12","key":"10.1016\/j.eprac.2021.07.011_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","article-title":"Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked?","volume":"25","author":"Ehlers","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.011_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.011_bib36","first-page":"174","article-title":"Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis","volume":"117","author":"Zeppa","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.011_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00428-013-1397-1","article-title":"Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis","volume":"462","author":"Chui","year":"2013","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.eprac.2021.07.011_bib38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1210\/jc.2011-2735","article-title":"Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease","volume":"97","author":"Fiore","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2021.07.011_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/j.1445-2197.2011.05687.x","article-title":"Recurrence of papillary thyroid carcinoma in a remnant pyramidal lobe","volume":"81","author":"Lee","year":"2011","journal-title":"ANZ J Surg"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","article-title":"Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma","volume":"77","author":"Cunha","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.011_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/thy.2008.0144","article-title":"Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis","volume":"19","author":"Kim","year":"2009","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.011_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cytogfr.2013.08.001","article-title":"CXCL8 in thyroid disease: from basic notions to potential applications in clinical practice","volume":"24","author":"Rotondi","year":"2013","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21011459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21011459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:32Z","timestamp":1761516752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21011459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1530891X21011459"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.07.011","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}